Neoadjuvant zoledronic acid for HER2-positive breast cancer: the Zo-NAnTax trial
唑来膦酸新辅助治疗 HER2 阳性乳腺癌：Zo-NAnTax 试验
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.3
doi:10.1177/1758835919853971
Susanne Crocamo, Renata Binato, Bruno de Paula, Giselle Vignal, Lídia Magalhães, Roberta Sarmento, Maria Theresa Accioly, Isabele Small, Sandra Gioia, Pedro Maroun, Pamela Moutinho, Vivianne Freitas, Karuline Catein, Eliana Abdelhay
